The protective nature of this modification is underscored by findings that chemical or genetic inhibition of MeCP2 lactylation leads to increased infarct volumes and exacerbated neurological deficits, indicating that MeCP2 lactylation functions as an endogenous defense mechanism against stroke-induced neuronal damage (Sun et al., 2025). This evidence concerns the gene MECP2 and stroke disorder.